Citation Impact
Citing Papers
Prospective identification of tumorigenic breast cancer cells
2003 Standout
Preferential induction of apoptosis for primary human leukemic stem cells
2002
The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)
2009
Fetal Hemoglobin, Sickling, and Sickle Cell Disease
1990
Hallmarks of Cancer: The Next Generation
2011 Standout
Poloxamers and poloxamines in nanoparticle engineering and experimental medicine
2000
Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin
2004 StandoutNobel
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
Role of interleukin‐7 in T‐cell development from hematopoietic stem cells
1998
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
2011 StandoutNature
The β-Thalassemias
1999 Standout
Langerhans'-Cell Histiocytosis (Histiocytosis X) -- A Clonal Proliferative Disease
1994 Standout
Applying the principles of stem-cell biology to cancer
2003
Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell Anemia
1995 Standout
Hematopoietic Growth Factors
1989
Cancer Metastasis: Building a Framework
2006 Standout
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
1994 StandoutNature
Origins of chromosome translocations in childhood leukaemia
2003
When Checkpoints Fail
1997 StandoutNobel
The Hedgehog and Wnt signalling pathways in cancer
2001 StandoutNature
Human acute myeloid leukemia stem cells
2003
NOVEL TREATMENT OPTIONS IN THE SEVERE β‐GLOBIN DISORDERS
1995
Cancer genes and the pathways they control
2004 Standout
Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function
2004 StandoutNobel
Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer
2005 Standout
Participation in Cancer Clinical Trials
2004 Standout
Investigational drugs in sickle cell anemia
2009
A cell stress signaling model of fetal hemoglobin induction: what doesn't kill red blood cells may make them stronger
2008
Identification and expansion of human colon-cancer-initiating cells
2006 StandoutNature
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer
1991 Standout
Prevention of a First Stroke by Transfusions in Children with Sickle Cell Anemia and Abnormal Results on Transcranial Doppler Ultrasonography
1998 Standout
Levels of Fetal Hemoglobin Necessary for Treatment of Sickle Cell Disease
1988
Sickle-cell disease
2010 Standout
Hematopoietic Stem-Cell Transplantation
2006 Standout
X‐chromosome inactivation patterns using HPRT and PGK polymorphisms in haematologically normal and post‐chemotherapy females
1991
ACUTE MYELOID LEUKAEMIA IN THE ELDERLY: BIOLOGY AND TREATMENT
1993
Clonal Chromosomal Abnormalities Showing Multiple-Cell-Lineage Involvement in Acute Myeloid Leukemia
1988
Stem cell origins of leukaemia and curability
1993
Stem Cells and Cancer
2004 Standout
Cancer stem cells: lessons from leukemia
2005
7 Increased HbF in adult life
1993
Clonal evolution in cancer
2012 StandoutNature
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
2000 StandoutNature
Sickle cell disease in Africa: burden and research priorities
2007
Phosphorus acquisition and use: critical adaptations by plants for securing a nonrenewable resource
2003 Standout
Long-term hydroxyurea treatment in young sickle cell patients
1999
Gold Nanorods: From Synthesis and Properties to Biological and Biomedical Applications
2009 Standout
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
2002 StandoutNature
Identification of human brain tumour initiating cells
2004 StandoutNature
Treatment of Sickle Cell Anemia with Hydroxyurea and Erythropoietin
1990
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
1997 Standout
Crypt stem cells as the cells-of-origin of intestinal cancer
2008 StandoutNature
Pharmacologic Modulation of Fetal Hemoglobin
2001
Pathophysiology and treatment of stroke in sickle-cell disease: present and future
2006
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
2008 Standout
Extended Therapy with Intravenous Arginine Butyrate in Patients with β-Hemoglobinopathies
1995
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
1999 Standout
The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin
1989
Nuclear reprogramming to a pluripotent state by three approaches
2010 StandoutNatureNobel
Hydroxyurea induction of hemoglobin F production in sickle cell disease: relationship between cytotoxicity and F cell production
1986
IL-7 Stimulates T Cell Renewal Without Increasing Viral Replication in Simian Immunodeficiency Virus-Infected Macaques
2003 StandoutNobel
Cytogenetically aberrant cells in the stem cell compartment (CD34+lin-) in acute myeloid leukemia.
1995
Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials
2003 Standout
Phenotypic characterization of human colorectal cancer stem cells
2007 Standout
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia [see comments]
1992
A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy
1996
5-azacytidine permits gene activation in a previously noninducible cell type
1985
Effects of hydroxyurea on hemoglobin F and water content in the red blood cells of dogs and of patients with sickle cell anemia
1991
Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin Immunoconjugate
1999
AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation
2000
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
2006 StandoutNature
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
A cautionary note regarding hydroxyurea in sickle cell disease
1994
Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism
1986 StandoutNobel
Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease
2016
Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia
1996
Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate
1994
Treatment of severe β‐thalassemia (patients) with myleran
1990
On the induction of fetal hemoglobin by butyrates: in vivo and in vitro studies with sodium butyrate and comparison of combination treatments with 5-AzaC and AraC
1989
Expression of a homologously recombined erythopoietin-SV40 T antigen fusion gene in mouse liver: evidence for erythropoietin production by Ito cells
1994 StandoutNobel
Spontaneous Transformation of Cultured Mouse Bone Marrow–Derived Stromal Cells
2006 StandoutNobel
Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia.
1984
Stem cell concepts renew cancer research
2008
Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial
1996
Treatment of baboon with vinblastine: insights into the mechanisms of pharmacologic stimulation of Hb F in the adult
1985
Evidence for nonclonal hematopoietic progenitor cell populations in bone marrow of patients with myelodysplastic syndromes
1994 StandoutNobel
Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin Immunoconjugate
1999
Induction of human γ globin gene expression by histone deacetylase inhibitors
2003
Correction of a human beta S-globin gene by gene targeting.
1991 StandoutNobel
DNA Methylation
1999
Highly purified primitive hematopoietic stem cells are PML-RARA negative and generate nonclonal progenitors in acute promyelocytic leukemia
1995
Locus control region-A gamma transgenic mice: a new model for studying the induction of fetal hemoglobin in the adult
1991
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma
2007 Standout
Clonal evolution in acute myeloid leukemia [editorial; comment]
1993
Cancerous stem cells can arise from pediatric brain tumors
2003 Standout
Mechanism of action of hydroxyurea.
1992
alpha-Amino butyric acid cannot reactivate the silenced gamma gene of the beta locus YAC transgenic mouse
1994
Lack of Expression of Thy-1 (CD90) on Acute Myeloid Leukemia Cells With Long-Term Proliferative Ability In Vitro and In Vivo
1997
Works of Robert Veith being referenced
Analysis of Treatment Failure in Acute Nonlymphocytic Leukemia Patients over Fifty Years of Age
1992
Arabinosylcytosine Induces Fetal Hemoglobin in Baboons by Perturbing Erythroid Cell Differentiation Kinetics
1984 Science
Independent changes of inorganic pyrophosphate and the AT/ADP or UTP/UDP ratios in plant cell suspension cultures
1990
Clonal Development, Stem-Cell Differentiation, and Clinical Remissions in Acute Nonlymphocytic Leukemia
1987
Stimulation of F-Cell Production in Patients with Sickle-Cell Anemia Treated with Cytarabine or Hydroxyurea
1985
RheothRx (Poloxamer 188) Injection for the Acute Painful Episode of Sickle Cell Disease: A Pilot Study
1997
Stimulation of Fetal Hemoglobin Synthesis by Erythropoietin in Baboons
1987